Nature's Sunshine Products Inc. has announced a share purchase agreement to acquire Fosun Industrial's interests in two joint ventures in China. This follows Fosun Pharma's sale of 2,854,607 shares, reducing its stake below 5% in Nature's Sunshine. The company will purchase Fosun's 20% interest in the Hong Kong Joint Venture for $3.9 million and the Shanghai Joint Venture for $3.1 million. The transactions are subject to regulatory approvals in China.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.